Changing patient character- istics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162:90 4. 74. Ghoreishi M, Foster N, Pasrija C, et al. Early operation in patients with mitral valve infective endocarditis and acute stroke is safe. Ann Thorac Surg. 2018;105:69 75. 13. PREGNANCY AND VHD 13.1. Initial Management of Women With VHD Before and During Pregnancy 1. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during preg- nancy. Eur Heart J. 2018;39:3165 241. 2. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515 21. 3. Elkayam U, Bitar F. Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol. 2005;46:223 30. 4. Le niak-Sobelga A, Tracz W, KostKiewicz M, et al. Clinical and echocardio- graphic assessment of pregnant women with valvular heart diseases ma- ternal and fetal outcome. Int J Cardiol. 2004;94:15 23. 5. Ducas RA, Javier DA, D Souza R, et al. Pregnancy outcomes in women with significant valve disease: a systematic review and meta-analysis. Heart. 2020;106:512 9. 6. Orwat S, Diller G-P, van Hagen IM, et al. Risk of pregnancy in moderate and severe aortic stenosis: from the multinational ROPAC registry. J Am Coll Cardiol. 2016;68:1727 37. 7. Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). Eur Heart J. 2019;40:3848 55. 8. Sliwa K, van Hagen IM, Budts W, et al. Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac CLINICAL STATEMENTS AND GUIDELINES Disease (ROPAC) of the European Society of Cardiology. Eur J Heart Fail. 2016;18:1119 28. 9. 